Potential of Allium cepa in thromboembolism in Ulcerative Colitis in Rats
Abstract
Colitis and coagulation influence each other and patients with colitis have been reported to have an increased risk of thromboembolic events. Allium cepa has been reported to have anti-coagulative activity and anti-inflammatory activity. This research was carried out to investigate the effect of Allium cepa on coagulation changes in colitis
Twenty eight rats weighed 180 ± 20g were used for this study. They were divided into four groups; Control group, Colitis group, Allium Cepa + Colitis group and Allium Cepa group. Allium Cepa + Colitis group and Allium Cepa were given 1ml/100g body weight of Allium cepa extract daily for 28days orally. Colitis was induced by a single dose of intra-rectal administration of 1ml/100g body weight of 6% acetic acid. Forty eight hours after the colitis induction, blood was taken by cardiac puncture for clotting time test, Prothrombin time (PT), Partial thromboplastin time with kaolin test (PTT.K), platelet count, Calcium ion and Potassium ion test.
Calcium ion was significantly decreased while potassium ion, platelet count, significantly increased and partial thromboplastin time shortened in colitis animals when compared with control. Calcium ion, potassium ion, platelet count and partial thromboplastin time showed no significant difference in Allium Cepa + Colitis group when compared with control. It can be concluded that Allium cepa has potential to reduced the risk of thromboembolism in colitis
Keywords: Colitis, Allium cepa, thromboembolism
Keywords:
Colitis, Allium cepa, thromboembolismDOI
https://doi.org/10.22270/jddt.v11i3-S.4879References
Abraham C and Cho JH, "Inflammatory bowel disease" N. Engl. J. Med., 2009; 361:2066-2078. https://doi.org/10.1056/NEJMra0804647
Cosnes J, Gower-Rousseau C, Seksik P and Cortot A, "Epidemiology and natural history of inflammatory bowel diseases." Gastroenterology, 2011; 140:1785-1794. https://doi.org/10.1053/j.gastro.2011.01.055
Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH, "Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface". Circulation. 2010; 122:2068 77. https://doi.org/10.1161/CIRCULATIONAHA.110.936773
Thornton P, Douglas J. "Coagulation in pregnancy." Best Pract Res Clin Obstet Gynaecol., 2010; 24:339 52. https://doi.org/10.1016/j.bpobgyn.2009.11.010
Yoshida H, Granger DN, "Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation." Inflamm Bowel Dis., 2009; 15:1245-1255. https://doi.org/10.1002/ibd.20896
Shen J, Ran ZH, Zhang Y, Cai Q, Yin HM, Zhou XT, Xiao SD. "Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis." Thromb Res., 2009; 123:604-611. https://doi.org/10.1016/j.thromres.2008.04.004
Spina L, Saibeni S, Battaglioli T, Peyvandi F, de Franchis R, Vecchi M, "Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia." Am J Gastroenterol; 2005; 100:2036-2041 https://doi.org/10.1111/j.1572-0241.2005.42029.x
Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M, "Inflammation and coagulation in inflammatory bowel disease: The clot thickens." Am J Gastroenterol, 2007; 102:174-186 https://doi.org/10.1111/j.1572-0241.2006.00943.x
Novotny DA, Rubin RJ, Slezak FA, Porter JA, "Arterial thromboembolic complications of inflammatory bowel disease. Report of three cases." Dis Colon Rectum, 1992; 35:193-196 https://doi.org/10.1007/BF02050678
Oldenburg B, Van Tuyl BA, van der Griend R, Fijnheer R, van Berge Henegouwen GP, "Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia." Dig Dis Sci, 2005; 50:235-240 https://doi.org/10.1007/s10620-005-1588-y
Talbot RW, Heppell J, Dozois RR, Beart RW Jr., "Vascular complications of inflammatory bowel disease." Mayo Clin Proc., 1986; 61:140-145 https://doi.org/10.1016/S0025-6196(12)65200-8
Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar J, Machold K, Scholz S, Vogelsang H, Novacek G, "Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?" Gut , 2004; 53:542-548 https://doi.org/10.1136/gut.2003.025411
Kume K, Yamasaki M, Tashiro M, Yoshikawa I, Otsuki M, "Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis." InternMed, 2007; 46:1323-1329 https://doi.org/10.2169/internalmedicine.46.0237
Bernstein CN, Blanchard JF, Houston DS, Wajda A, "The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study." Thromb Haemost , 2001; 85:430-434 https://doi.org/10.1055/s-0037-1615600
Bernstein CN, Wajda A, Blanchard JF, "The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population- based study." Clin Gastroenterol Hepatol, 2008; 6:41-45 https://doi.org/10.1016/j.cgh.2007.09.016
Breu W, "Allium cepa L. (onion) Part 1: Chemistry and analysis." Phytomedicine, 1996; 3:293-306. [CrossRef] https://doi.org/10.1016/S0944-7113(96)80069-9
Fritsch RM, Friesen N, "Evolution, domestication and taxonomy. In Allium crop science: Recent advances; Rabinowitch, H.D., Currah, L., Eds.; CABI publishing: Stratford-upon-Avon, UK,; 2002; pp. 5-30." ISBN 0-85199- 510-1. https://doi.org/10.1079/9780851995106.0005
Angiosperm Phylogeny Group,. "An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III." Bot. J. Linn. Soc., 2009; 161:105-121. https://doi.org/10.1111/j.1095-8339.2009.00996.x
Peruzzi L, Carta A, "Altinordu, F. Chromosome diversity and evolution in Allium (Allioideae Amaryllidaceae). Plant." Biosyst., 2017; 151:212-220. [CrossRef] https://doi.org/10.1080/11263504.2016.1149123
Chisty M., Quddus R., Islam B and Khan B, "Effect of onion extract on immune response in rabbits." Bangladesh Medical Research Council Bulletin. 1996; 22:81-85.
Gazzani G, Papetti A, Daglia M, Berte F, and Gregotti C, "Protective activity of water soluble components of some common diet vegetable on rat liver microsome and the effects of the thermal treatment" Journal of Agriculture and Food Chemistry, 1998; 46:4123-4127. https://doi.org/10.1021/jf980301g
Sanderson J, Mclauchlin W, Williamson G, "Quercetin inhibits hydrogen peroxide-induced oxidization of the rat lens." Free Radical in Biology and Medicine, 1999; 26(6):639-645. https://doi.org/10.1016/S0891-5849(98)00262-7
Shimura M, ZhouY, Asada Y, Yoshikawa ., Hatake K, Takaku F, Ishizaka Y, "Inhibition of Vpr-induced cell cycle abnormality by quercetin: A novel strategy for searching compounds targeting Vpr." Biochemical and Biophysics Research Communications, 1999; 261:308-316. https://doi.org/10.1006/bbrc.1999.0994
Hussein JS, Oraby FS and El-Shafey N, Anti hepatotoxic Effect of Garlic and Onion Oils on Ethanol-induced Liver Injury in Rats. J of Appl Sci Res. 2007; 3(11):1527-153.,
Nation S, Yamaguchi N,Yokko Y, "Antioxidative activities of vegetables of the Allium species (studies on natural antioxidants, part II)." Nippon Shokuhin Kogyo Gakkaishi, 1981; 28:230-291.
Morimitsu Y, Morioka Y, Kawakishi S, "Inhibitors of platelet aggregation generated from mixture of Allium species and/or S-alk(en)yl-Lcysteine sulfoxides." Journal of Agriculture and Food Chemistry, 1992; 40:368- 375. https://doi.org/10.1021/jf00015a002
McKenna R, Bachmann F, Miro-Quesada M, "Thromboembolism in patients with abnormally short activated thromboplastin time." Thromb Haemost., 1977; 38:893-899. https://doi.org/10.1055/s-0038-1651907
Singh VK, Singh DK, ' Pharmacological Effects of Garlic (Allium sativum L.).' Annu Rev Biomed Sc., 2008; 10:6-26. https://doi.org/10.5016/1806-8774.2008.v10p6
Goldman IL, Kopelberg M, Debaene JE "Antiplatelet activity in onion (Allium cepa) is sulfur dependent." Thrombosis and. Haemostasis; 1996; 76:450-452. https://doi.org/10.1055/s-0038-1650598
Imad M. Taj Eldin, Elhadi M, Ahmed and Abd Elwahab HM, "Hypoglycemic Activity and Regeneration of Pancreatic Beta-cells Produced by Allium cepa in Alloxan-induced Diabetic Rats." Omdurman Journal of Pharmaceutical, 2009; 1(5):562-8
Ige SF and Akhigbe RE, Common onion (Allium cepa) extract reverses cadmium-induced organ toxicity and dyslipidaemia via redox alteration in rats. Pathophysiology, 2013; 20:269-274 https://doi.org/10.1016/j.pathophys.2013.04.002
Zoja C, Noris M, Corna D, Vigano G, Perico N, de Gaetano G & Remuzzi G . Lab Invest, 1991; 65:479-483.
Masonobu F, Osamu K, Yoshio A, Akira A, Kehchi M, Kohsuke T, Atsushi T, Michio S, Yoshihide F, Masamichi F, Yoshiaki M, Tadao B, "Prebiotic treatment of experimental colitis with germinated barley foodstuff; a comparison with probiotic or antibiotic treatment." Int. J. Mol. Med., 2002; 9:65-70.
Wallace JL, Keenan CM, "An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis." Am I Physiol., 1990; 258:G527-3427. https://doi.org/10.1152/ajpgi.1990.258.4.G527
Aleisha AM, Al- Rejajie SS, Ola MS, Ahmed MM, "Pretreatment of gymnema sylvestre revealed the protection against acetic acid induced ulcerative colitis in rats."BMC Complementary and Alternative Medicine, 2014; 14(1). https://doi.org/10.1186/1472-6882-14-49
McLellan DS, Jurd K M."Anticoagulants from marine algae." Blood coagulation and fibrinolysis, 1992; 3:69-77. https://doi.org/10.1097/00001721-199202000-00011
Owusu G, David D, George K, Newman O, Aaron O, Babatunde M, Duduyemi and Charles A, "Acetic acid induced ulcerative colitis in spraque dawley rats is suppressed by hydroehanolicextract of cordial vignei leaves through reduced serum levels of TNF-α and IL-6." International Journal of Chronic Diseases, . 2020; 87:85-497. https://doi.org/10.1155/2020/8785497
Harputluoglu MM, Demirel U, Yucel N,. "The effects of Gingko biloba extract on acetic acid-induced colitis in rats."The Turkish Journal of Gastroenterology: the official journal of Turkish Societyl of Gastroenterology, 2006; 17(3):177-182.
El-Abhar HS, Hammad A, Gawad A, "Modulating effect of ginger extract on rats with ulcerative colitis" Journal of Ethnopharmacology, 2008; vol. 118, no. 3, pp. 367-372. https://doi.org/10.1016/j.jep.2008.04.026
Wenzl HH, "Diarrhea in chronic inflammatory bowel diseases." Gastroenterol Clin North Am., 2012; 41(3):651-75. https://doi.org/10.1016/j.gtc.2012.06.006
Kazuo M, Hikaru W, Nobuo H, Kohji S and Yoshio G, "Studies on Blood Coagulation in Ulcerative Colitis and Crohn's Disease." Tohoku J. exp. Med. 1980; 132:93-101 https://doi.org/10.1620/tjem.132.93
Dong WG, Liu SP, Zhu HH, Luo HS and Yu JP. "Abnormal function of platelets and role of an¬gelica sinensis in patients with ulcerative coli¬tis." World J Gastroenterol, 2004; 10:606-609. https://doi.org/10.3748/wjg.v10.i4.606
Van Bodegraven AA, Schoorl M, Baak JP, Linskens RK,Bartels PC, Tunyman HA "Hemostatic imbalance in active and quiescent ulcerative colitis." Am J Gastroenterol., 2001; 96(2):487-493. https://doi.org/10.1111/j.1572-0241.2001.03532.x
Larsen TB, Nielsen JN, Fredholm L, "Platelets and anticoagulant capacity in patients with inflammatory bowel disease", Pathophysiol Haemost Thromb., 2002; 32(2):92-96. https://doi.org/10.1159/000065082
Alkim H, Ayaz S, Alkim C, Ulker A and Sahin B,. "Continuous Active State of Coagulation System in Patients With Nonthrombotic Inflammatory Bowel Disease." Clin Appl Thromb Hemost; 2011; 17:600-4. https://doi.org/10.1177/1076029611405034
Can D, Aliye S, Tulin K, Ali T, Hatice D, Sevim P, Cengiz B, Haci MS, Remzi D, Oya O, "Coagulation parameters in inflammatory bowel disease." Int J Clin Exp Med, 2014; 7(5):1442-1448.
Payzin B, Adakan FY, Yalcin HC, Cetinkaya GS, Berkmen S, Eraslan S and Unsal B, "Natural co¬agulation inhibitory proteins and activated pro¬tein C resistance in Turkish patients with in¬flammatory bowel disease." Turk J Gastroenterol, 2006; 17:183-190.
Landi G, D'Angelo A, Boccardi E, et al "Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability." Arch Neurol.,1992; 49:279-283 https://doi.org/10.1001/archneur.1992.00530270093024
Aboud MR, Ma DD. 'Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistance' Clinical & Laboratory Haematology, 2001; 23(6):411-6. [PubMed: 11843891] https://doi.org/10.1046/j.1365-2257.2001.00421.x
Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM, "A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism." Blood., 2004; 104(12):3631-4. [PubMed: 15297315]. https://doi.org/10.1182/blood-2004-03-1042
Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA, "Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time." J Thromb Haemost; 2006 4(4):752- 6. [PubMed: 16634742] https://doi.org/10.1111/j.1538-7836.2006.01868.x
Svensson PJ, Dahlback B, "Resistance to activated protein C as a basis for venous thrombosis." N Engl J Med., 1994; 330(8):517-522. [PubMed: 8302317] https://doi.org/10.1056/NEJM199402243300801
Lam A, Borda IT, Inwood MJ and Thomson S, "Coagulation studies in ulcerative colitis and Crohn's disease." Gastroenterology; 1975; 68: 245 251. https://doi.org/10.1016/S0016-5085(75)80005-9
Caroline H, Viveca R, Uma M, "Micronutrient deficiencies in inflammatory bowel disease." Inflamm Bowel Dis; 2012; 18:1961-1981. https://doi.org/10.1002/ibd.22906
Bronner F, "Mechanism of intestinal absorption." Chem. ; 2003; 88:387- 393. https://doi.org/10.1002/jcb.10330
Krela-Kazmierczak I, Szymczak A, Lykowsks-Szuber L, Elder P, Horst- SikorskaW, "The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel disease." Arch Med Sci. AMS, 2015; 11:1028-1032.
Weiner ID, Linas S, "Disorder of potassium metabolism, comprehensive clinical nephrology 6th ed." Elseivier, 2019; pp. 111-123
Published
Abstract Display: 575 
PDF Downloads: 664 PDF Downloads: 47 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.